An anti-CD19-exosome delivery system navigates the blood-brain barrier for targeting of central nervous system lymphoma
{{output}}
Background: High-dose methotrexate (HD-MTX) serves as the cornerstone of central nervous system lymphoma (CNSL) treatment, but its efficacy is limited due to low blood-brain barrier (BBB) penetration and adverse effects. This stu... ...
